Roger McIntyre, MD

Roger McIntyre, MD, is the head of the Mood Disorders Psychopharmacology Unit at the University Health Network, in Toronto, Canada, and a member of the Psychiatry Advisor Editorial Board.

All articles by Roger McIntyre, MD

graphic depiction of brain activity

Depressive Disorder

Cognition in Depression: A Critical Domain for Health Outcomes, Measurement, and Treatment

By

Roger McIntyre, MD

September 20, 2016

Dr. Roger McIntyre suggests that the clinical relevance of cognitive dysfunction for any individual patient can only be adjudicated on a case-by-case basis.

Treating Co-Morbid Sleep Problems with Psychiatric Disorders

Sleep-Wake Disorders

Investigating the Relationship Between Inflammation and Sleep Quality

By

Roger McIntyre, MD

April 7, 2016

The association between sleep disturbance and inflammation provides support for the possible etiopathogenic role of chronobiological disturbances.

Implications of the Mixed Features Specifier

By

Roger McIntyre, MD

December 23, 2015

The mixed features specifier identifies a subpopulation that is often misdiagnosed.

Can Subtyping Depressive Symptoms Predict Antidepressant Response?

By

Roger McIntyre, MD

October 15, 2015

Many clinicians have a working assumption that subtyping patients is a critical process relevant to antidepressant treatment selection.

How Neuroinflammation May Play a Role in Mood Disorders

By

Roger McIntyre, MD

March 27, 2015

Clinicians should encourage patients to make lifestyle changes that will favorably impact the body’s inflammatory system.

Next post in Mood Disorders

Improving Access to Treatment for Women with Perinatal Depression